Pear Therapeutics
closedPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need. Learn more
Launch date
–
Employees
Market cap
€623k
Enterprise valuation
€627k (Public information from May 2023)
Share price
$0 PEAR
Boston Massachusetts (HQ)
- hard tech
- biotechnology
- core ai
- testing
- entertainment
- ai applications
- oncology
- open source
- aviation & aerospace
- predictive analytics
- verified unicorns and $1b exits
- genetics
- dna
- intellectual property
- neurology
- user behavior
- surgery
- cardiology
- genome engineering
- patient care
- tech for patients
- children
- tech for biotech & pharma
- spac ipo announced
- digital therapeutics
- icarus: from unicorn to failure
Authorizing premium user...